From photography to treatment for chronic wounds; a look at how innovation thrived during the pressures of the pandemic.
Tech Talks14 Kesä 2024

From photography to treatment for chronic wounds; a look at how innovation thrived during the pressures of the pandemic.

Today David talks to Polaroid Therapeutics CEO Ran Frankel, a company who took the complex chemistry involved in photography and applied it to healthtech during the pandemic to try and ease the crisis. In the process they made discoveries that have led to better treatment for wound management and chronic wounds in particular. So, how did the company spin off from such an unlikely source, and how is Ran leading the organisation into the future?


Want to join us for our Tech Flix screening at AWS? https://bit.ly/3VG26Ih



Tech Talks is powered by Nash Squared, the leading global provider of technology and talent solutions. Find out more about our solutions at www.nashsquared.com

The music on Tech Talks is created by London artist Lemzi: www.lemzi.com

Jaksot(842)

Inside the Seismic Legal Fight That Just Rewrote the Rules for AI

Inside the Seismic Legal Fight That Just Rewrote the Rules for AI

Not every decision that shapes the future of technology happens in a coding sprint. Some unfold slowly, over years and years, and end up in the highest court.Today, we’re looking at a landmark moment ...

27 Helmi 27min

Job For Life? Why You Need To Learn 40 New Skills Every Four Years

Job For Life? Why You Need To Learn 40 New Skills Every Four Years

For 200 years, a university diploma was enough to launch a 40-year career. Today, employers demand 40 new skills every four years. Anthony Salcito, Coursera VP and General Manager and former Microsoft...

25 Helmi 32min

The Truth About AI Strategy: Why Boardroom Disagreement Guarantees Failure

The Truth About AI Strategy: Why Boardroom Disagreement Guarantees Failure

Many traditional enterprises mistakenly believe that simply adopting cloud tools internally means they have a working AI strategy. In reality, true AI readiness requires breaking down entrenched data ...

23 Helmi 30min

The Assumption That Broke COVID Testing (And Why We Need Synthetic Humans)

The Assumption That Broke COVID Testing (And Why We Need Synthetic Humans)

When the UK government rolled out COVID home testing, experts assumed 70-80% of people would return the kits. The reality? Only 30% did. So why do leaders consistently misjudge their audiences? David ...

20 Helmi 33min

Why We Cloned Our Dad’s Receptionist: The Story Behind Linda AI

Why We Cloned Our Dad’s Receptionist: The Story Behind Linda AI

From Goldman Sachs traders to health-tech founders, sisters India and Portia O’Connor are proving that in the age of AI, specificity is everything. They explain why generalist models fail in complex w...

18 Helmi 35min

 The Horizontal Specialist: How to Escape the Vertical Career Ladder

The Horizontal Specialist: How to Escape the Vertical Career Ladder

We are taught to be vertical specialists: stay in your lane, climb the ladder, and fit into a box. But Casey Woo, founder of the Operators Guild, argues that in high-growth tech, the "lane" is actuall...

16 Helmi 38min

Agentic AI: What Happens When The Tools Stop Asking For Permission?

Agentic AI: What Happens When The Tools Stop Asking For Permission?

We’ve accepted AI as a copilot, but Channing Ferrer (Chief Revenue Officer and CEO of the Americas at Brevo) argues we are rapidly approaching the era where software executes entire workflows without ...

13 Helmi 30min

In The Middle Of The Ozempic Gold Rush Habitual Refused the “Easy” Revenue: We Find Out Why

In The Middle Of The Ozempic Gold Rush Habitual Refused the “Easy” Revenue: We Find Out Why

GLP-1 medications like Ozempic and Mounjaro have changed the world, but they aren't a silver bullet. Napala Pratini, co-founder of Habitual, joins David to discuss the “hard stuff” behind the hype: be...

11 Helmi 32min